# Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas

> **NCT06381570** · EARLY_PHASE1 · RECRUITING · sponsor: **Daniel Morgenstern** · enrollment: 57 (estimated)

## Conditions studied

- Low-grade Glioma

## Interventions

- **DRUG:** Tovorafenib
- **DRUG:** Vinblastine

## Key facts

- **NCT ID:** NCT06381570
- **Lead sponsor:** Daniel Morgenstern
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-21
- **Primary completion:** 2027-03-21
- **Final completion:** 2029-03-21
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2025-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06381570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06381570, "Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06381570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*